Skip to main content

Table 4 Effects of sub-acute oral administration of UA and APAP on relative organ ROW of Wistar rats (n = 5/sex)

From: Toxicological evaluations of betulinic acid and ursolic acid; common constituents of Houttuynia cordata used as an anthelmintic by the Naga tribes in North-east India

Organ

G-I

Control

G-II

UA

1 mg/kg

G-III

UA

5 mg/kg

G-IV

UA

10 mg/kg

G-V

APAP

50 mg/kg

Satellite groups

G-VI

Control

G-VII

UA

10 mg/kg

G-VIII

APAP

50 mg/kg

Female

 Heart

0.57 ± 0.01

0.67 ± 0.05

0.68 ± 0.06

0.65 ± 0.08

0.62 ± 0.06

0.59 ± 0.13

0.62 ± 0.07

0.77 ± 0.03

 Liver

5.81 ± 0.21

5.66 ± 0.69

5.28 ± 0.52

4.93 ± 0.55a

6.82 ± 1.05b

5.76 ± 0.38

5.82 ± 0.55

5.55 ± 0.31

 Brain

1.09 ± 0.02

1.02 ± 0.02

1.02 ± 0.02

1.02 ± 0.01

0.99 ± 0.01

0.99 ± 0.00

0.99 ± 0.00

0.99 ± 0.00

 Spleen

0.49 ± 0.03

0.42 ± 0.05

0.45 ± 0.06

0.35 ± 0.05a

0.71 ± 0.05a

0.46 ± 0.05

0.39 ± 0.08

0.43 ± 0.07

 Adrenal

0.03 ± 0.00

0.03 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

 Kidney (L)

0.58 ± 0.10

0.71 ± 0.02

0.63 ± 0.04

0.77 ± 0.04

0.73 ± 0.09

0.57 ± 0.06

0.55 ± 0.09

0.57 ± 0.02

 Kidney (R)

0.58 ± 0.12

0.73 ± 0.01

0.73 ± 0.04

0.72 ± 0.08

0.71 ± 0.12

0.66 ± 0.03

0.73 ± 0.04

0.57 ± 0.01

 Ovary

0.06 ± 0.00

0.06 ± 0.00

0.06 ± 0.01

0.06 ± 0.00

0.06 ± 0.00

0.06 ± 0.00

0.06 ± 0.00

0.06 ± 0.00

Male

 Heart

0.61 ± 0.03

0.65 ± 0.09

0.69 ± 0.10

0.72 ± 0.09

0.62 ± 0.02

0.62 ± 0.09

0.62 ± 0.08

0.77 ± 0.04

 Liver

6.46 ± 0.15

6.55 ± 0.95

6.21 ± 0.18

5.76 ± 0.50a

7.13 ± 1.20c

6.19 ± 1.09

6.51 ± 0.80

7.23 ± 0.57

 Brain

1.28 ± 0.10

1.03 ± 0.01

1.05 ± 0.02

1.01 ± 0.01

1.01 ± 0.01

1.01 ± 0.02

1.02 ± 0.01

1.01 ± 0.01

 Spleen

0.44 ± 0.03

0.48 ± 0.06

0.34 ± 0.03

0.32 ± 0.04a

0.76 ± 0.12a

0.49 ± 0.07

0.48 ± 0.07

0.53 ± 0.08

 Adrenal

0.03 ± 0.00

0.03 ± 0.00

0.03 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.02 ± 0.00

0.03 ± 0.00

 Kidney (L)

0.60 ± 0.14

0.72 ± 0.01

0.74 ± 0.03

0.70 ± 0.02

0.77 ± 0.02

0.66 ± 0.09

0.63 ± 0.04

0.55 ± 0.09

 Kidney (R)

0.56 ± 0.10

0.78 ± 0.01

0.72 ± 0.03

0.71 ± 0.09

0.76 ± 0.14

0.63 ± 0.07

0.72 ± 0.03

0.64 ± 0.04

 Testis (L)

0.71 ± 0.04

0.76 ± 0.05

0.69 ± 0.03

0.77 ± 0.15

0.86 ± 0.06

0.75 ± 0.02

0.69 ± 0.03

0.73 ± 0.03

 Testis (R)

0.74 ± 0.03

0.71 ± 0.05

0.74 ± 0.03

0.67 ± 0.11

0.66 ± 0.15

0.72 ± 0.07

0.74 ± 0.03

0.78 ± 0.01

  1. Data are expressed as mean ± SEM; treatment: G-II to G-IV = 4 weeks, G-V to G-VI = 6 weeks
  2. ap < 0.05 vs control; one-way ANOVA. L—left, R—right